Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases

  4. Siemens Healthineers accelerates and improves Magnetic Resonance Imaging with Artificial Intelligence

Press release

Siemens Healthineers accelerates and improves Magnetic Resonance Imaging with Artificial Intelligence

European Congress of Radiology (ECR), July 13-17, 2022

Published on July 13, 2022
Deep Resolve

Highly accelerated MR acquisitions usually result in strong noise contamination when using conventional reconstruction. With Deep Resolve, previously unthinkable acceleration factors can be applied, with consistently high image quality.

Deep Resolve

The combination of Deep Resolve and Simultaneous Multi-Slice enables the acquisition of a complete knee exam in just two minutes scan time.

Download this press release

(pdf, 182.34 KB)

Download image 1

(png, 1811.16 KB)

Download image 2

(png, 2927.09 KB)
1

Data on file

2

Deep Resolve Gain for MAGNETOM Sola Fit and Deep Resolve Boost for MAGNETOM Sola, MAGNETOM Sola Fit, and MAGNETOM Altea are pending 510(k) clearance and are not yet commercially available in the United States and in all other countries. Their future availability cannot be ensured.

Siemens Healthineers 2022

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers and its regional companies is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. In fiscal 2021, which ended on September 30, 2021, Siemens Healthineers, which has approximately 66,000 employees worldwide, generated revenue of €18.0 billion and adjusted EBIT of €3.1 billion. Further information is available at www.siemens-healthineers.com.